¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Èñ±ÍÁúȯ À¯ÀüÀÚ °Ë»ç ½ÃÀå : ºÐ¼® ¹× ¿¹Ãø(2023-2033³â)
Asia-Pacific Rare Disease Genetic Testing Market: Analysis and Forecast, 2023-2033
»óǰÄÚµå : 1439025
¸®¼­Ä¡»ç : BIS Research Inc.
¹ßÇàÀÏ : 2024³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,950 £Ü 4,268,000
PDF and Excel (1-3 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 3¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,450 £Ü 6,438,000
PDF and Excel (Global License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÁÖ¿ä ½ÃÀå Åë°è
¿¹Ãø ±â°£ 2023-2033³â
2023³â Æò°¡ 5¾ï 8,000¸¸ ´Þ·¯
2033³â Àü¸Á 24¾ï ´Þ·¯
CAGR 15.25%

¾Æ½Ã¾ÆÅÂÆò¾ç Èñ±ÍÁúȯ À¯ÀüÀÚ °Ë»ç ½ÃÀå ±Ô¸ð´Â 2023³â 5¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº 2033³â 24¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2033³â µ¿¾È 15.25%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀüÀå À¯Àüü ¿°±â¼­¿­ ºÐ¼®(WGS)À̳ª ÀüÀå ¿¢¼Ø ¿°±â¼­¿­ ºÐ¼®(WES)°ú °°Àº ÷´Ü ±â¼úÀº °¢°¢ °³ÀÎÀÇ Àüü À¯Àü ÄÚµå(°Ô³ð) ¶Ç´Â ƯÁ¤ ´Ü¹éÁú ÄÚµå ¿µ¿ª(¿¢¼Ø)À» ºÐ¼®ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº Èñ±Í Áúȯ°ú °ü·ÃµÈ À¯ÀüÀû º¯ÀÌ, µ¹¿¬º¯ÀÌ ¹× ÀÌ»óÀ» °¨ÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Èñ±ÍÁúȯ À¯ÀüÀÚ °Ë»ç ½ÃÀåÀº ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÎÁöµµ Çâ»ó, À¯ÀüÀÚ °Ë»ç ±â¼úÀÇ ¹ßÀü, ÀÇ·áºñ Áõ°¡ µîÀÌ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ Àα¸°¡ ¸¹°í ´Ù¾çÇÑ À¯ÀüÀû ÇÁ·ÎÇÊÀº À¯ÀüÀÚ °Ë»ç Á¦°ø¾÷ü¿¡°Ô Å« ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¼±Çϰí À¯ÀüÀÚ °Ë»ç ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇÏ·Á´Â Á¤ºÎÀÇ ³ë·ÂÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ±â°ü, ¿¬±¸ ±â°ü ¹× ¾÷°è °ü°èÀÚµéÀÇ Çù·ÂÀº ÀÌ Áö¿ªÀÇ Æ¯¼öÇÑ ¿ä±¸¿¡ ¸Â´Â Çõ½ÅÀûÀÎ À¯ÀüÀÚ °Ë»ç ¼Ö·ç¼ÇÀÇ °³¹ß ¹× µµÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Á¤¹ÐÀÇ·á¿Í ¸ÂÃãÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ APAC Èñ±ÍÁúȯ À¯ÀüÀÚ °Ë»ç ½ÃÀåÀº ´çºÐ°£ Áö¼ÓÀûÀÎ ¼ºÀå°ú Çõ½ÅÀ» °ÅµìÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

ÀÌ º¸°í¼­´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Èñ±ÍÁúȯ À¯ÀüÀÚ °Ë»ç ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² Áúº´ À¯Çüº°, ±â¼úº°, ±¹°¡º° µ¿Çâ, ½ÃÀå ÁøÀÔ ±â¾÷ °³¿ä µîÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¦1Àå ½ÃÀå

Á¦2Àå Èñ±ÍÁúȯ À¯ÀüÀÚ °Ë»ç ½ÃÀå(Áö¿ªº°)

Á¦3Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Asia Pacific Rare Disease Genetic Testing Market Expected to Reach $2.40 Billion by 2033

Introduction to Asia-Pacific Rare Disease Genetic Testing Market

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$0.58 Billion
2033 Forecast$2.40 Billion
CAGR15.25%

The Asia-Pacific rare disease genetic testing market was valued at $0.58 billion in 2023 and is anticipated to reach $2.40 billion by 2033, witnessing a CAGR of 15.25% during the forecast period 2023-2033. Advanced technologies like whole-genome sequencing (WGS) and whole-exome sequencing (WES) analyze an individual's entire genetic code (genome) or specific protein-coding regions (exome), respectively. They aid in detecting genetic variations, mutations, or abnormalities linked to rare diseases.

Market Introduction

The Asia-Pacific (APAC) rare disease genetic testing market is witnessing notable growth driven by various factors. Increased awareness, advancements in genetic testing technologies, and rising healthcare expenditure contribute to market expansion. Moreover, the region's large population base and diverse genetic profiles present significant opportunities for genetic testing providers. Government initiatives aimed at improving healthcare infrastructure and expanding access to genetic testing services further propel market growth. Additionally, collaborations between healthcare organizations, research institutions, and industry players facilitate the development and adoption of innovative genetic testing solutions tailored to the region's specific needs. With a growing focus on precision medicine and personalized healthcare, the APAC rare disease genetic testing market is poised for continued expansion and innovation in the foreseeable future.

Market Segmentation:

Segmentation 1: by Disease Type

Segmentation 2: by Technology

Segmentation 3: by Country

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The APAC rare disease genetic testing market has been extensively segmented based on various categories, such as disease type, technology, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.

Competitive Strategy: The APAC rare disease genetic testing market has numerous established players paving their way into providing tests, panels, and assays in the market. Key players in the global rare disease genetic testing market analyzed and profiled in the study involve established players offering various disease-specific panels and multiplex instruments.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Some of the prominent names established in this market are:

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1 Market

2 Rare Disease Genetic Testing Market (by Region)

3 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â